850311C-25MG Display Image

DOCP

Code: 850311C-25MG D2-231

Application

DOCP is suitable for use in the preparation of large unilamellar vesicles (LUVs) and in the preparation of liposomes.

General description

read more

Your Price
£178.00 25MG
£213.60 inc. VAT

Application

DOCP is suitable for use in the preparation of large unilamellar vesicles (LUVs) and in the preparation of liposomes.

General description

Inverse-phosphocholine lipids, a remix of a common phospholipid, contain headgroups with an inverted charge orientation relative to phosphocholine (PC) lipids. The iPC lipid headgroup has a quaternary amine adjacent to the bilayer interface and a phosphate that extends into the aqueous phase. Therefore iPC lipids afford a unique opportunity to investigate the biophysical and bioactivity-related ramifications of a charge inversion at the bilayer surface.

DOCP is a zwitterionic /negatively charged lipid. It possess an inverse headgroup This synthetic molecule has stronger affinity than 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS).

Packaging

5 mL Clear Glass Sealed Ampule (850311C-25mg)

5 mL Clear Glass Sealed Ampule (850311C-200mg)

assay>99% (TLC)
concentration10 mg/mL (850311C-25mg), 25 mg/mL (850311C-200mg)
formliquid
manufacturer/tradenameAvanti Polar Lipids 850311C
packagingpkg of 2 × 4 mL (850311C-200mg), pkg of 1 × 2.5 mL (850311C-25mg)
shipped indry ice
storage temp.−20°C
Cas Number1360461-57-9
This product has met the following criteria: